Hopelessness, a potential endophenotpye for suicidal behavior, is influenced by TPH2 gene variants

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 155-160

  Lazary, Judit ^a   Viczena, Veronika ^a   Dome, Peter ^a   Chase, Diana ^b   Juhasz, Gabriella ^b   Bagdy, Gyorgy ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Beck's Hopelessness Scale; Depression; Haplotype analysis; Suicide; Tryptophan hydroxylase

Indexed keywords

TRYPTOPHAN HYDROXYLASE;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; ENDOPHENOTYPE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HOPELESSNESS; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RISK ASSESSMENT; SELF-RATING DEPRESSION SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE; TPH2 GENE;

ADULT; EMOTIONS; ENDOPHENOTYPES; FEMALE; GENETIC VARIATION; HUMANS; MALE; RISK FACTORS; SUICIDAL IDEATION; SUICIDE; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 82555179155     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.09.001     Document Type: Article

References (53)

1. The International HapMap Project. Nature 2003, 426(6968):789-796.
2. Agrell B., Dehlin O. Comparison of six depression rating scales in geriatric stroke patients. Stroke 1989, 20(9):1190-1194.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
4. Beck A.T., Brown G.K., Steer R.A., Dahlsgaard K.K., Grisham J.R. Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide & Life-Threatening Behavior 1999, 29(1):1-9.
5. Beck A.T., Steer R.A., Beck J.S., Newman C.F. Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. Suicide & Life-Threatening Behavior 1993, 23(2):139-145.
6. Beck A.T., Steer R.A., Kovacs M., Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. The American Journal of Psychiatry 1985, 142(5):559-563.
7. Beck A.T., Weissman A., Lester D., Trexler L. The measurement of pessimism: the hopelessness scale. Journal of Consulting and Clinical Psychology 1974, 42(6):861-865.
8. Biggs J.T., Wylie L.T., Ziegler V.E. Validity of the Zung Self-rating Depression Scale. The British Journal of Psychiatry 1978, 132:381-385.
9. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Molecular Psychiatry 2005, 10(9):884-888. 805.
10. Courtet P., Jollant F., Castelnau D., Buresi C., Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 2005, 133C(1):25-33.
11. Freeman B., Smith N., Curtis C., Huckett L., Mill J., Craig I.W. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behavior Genetics 2003, 33(1):67-72.
12. Fudalej S., Ilgen M., Fudalej M., Kostrzewa G., Barry K., Wojnar M., et al. Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide. Suicide & Life-Threatening Behavior 2011, 40(6):553-560.
13. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
14. Gabrys J.B., Peters K. Reliability, discriminant and predictive validity of the Zung Self-rating Depression Scale. Psychological Reports 1985, 57(3 Pt 2):1091-1096.
15. Garriock H.A., Allen J.J., Delgado P., Nahaz Z., Kling M.A., Carpenter L., et al. Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Molecular Psychiatry 2005, 10(11):976-977.
16. Gonda X., Fountoulakis K.N., Juhasz G., Rihmer Z., Lazary J., Laszik A., et al. Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. European Archives of Psychiatry and Clinical Neuroscience 2009, 259(2):106-113.
17. Gonzalez J.R., Armengol L., Sole X., Guino E., Mercader J.M., Estivill X., et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23(5):644-645.
18. Hellhammer D.H., Rea M.A., Bell M., Belkien L., Ludwig M. Learned helplessness: effects on brain monoamines and the pituitary-gonadal axis. Pharmacology Biochemistry and Behavior 1984, 21(4):481-485.
19. Kangelaris K.N., Vittinghoff E., Otte C., Na B., Auerbach A.D., Whooley M.A. Association between a serotonin transporter gene variant and hopelessness among men in the heart and soul study. Journal of General Internal Medicine 2010, 25(10):1030-1037.
20. Ke L., Qi Z.Y., Ping Y., Ren C.Y. Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Research 2006, 1122(1):24-26.
21. Large M., Smith G., Sharma S., Nielssen O., Singh S.P. Systematic review and meta-analysis of the clinical factors associated with the suicide of psychiatric in-patients. Acta Psychiatrica Scandinavica 2011, 124(1):18-19.
22. Lazary J., Lazary A., Gonda X., Benko A., Molnar E., Juhasz G., et al. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biological Psychiatry 2008, 64(6):498-504.
23. Lim J.E., Pinsonneault J., Sadee W., Saffen D. Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Molecular Psychiatry 2007, 12(5):491-501.
24. Lopez de Lara C., Brezo J., Rouleau G., Lesage A., Dumont M., Alda M., et al. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biological Psychiatry 2007, 62(1):72-80.
25. Malkesman O., Pine D.S., Tragon T., Austin D.R., Henter I.D., Chen G., et al. Animal models of suicide-trait-related behaviors. Trends in Pharmacological Sciences 2009, 30(4):165-173.
26. Mann J.J., Arango V.A., Avenevoli S., Brent D.A., Champagne F.A., Clayton P., et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biological Psychiatry 2009, 65(7):556-563.
27. Milnes D., Owens D., Blenkiron P. Problems reported by self-harm patients: perception, hopelessness, and suicidal intent. Journal of Psychosomatic Research 2002, 53(3):819-822.
28. Minkoff K., Bergman E., Beck A.T., Beck R. Hopelessness, depression, and attempted suicide. The American Journal of Psychiatry 1973, 130(4):455-459.
29. Mouri K., Hishimoto A., Fukutake M., Shiroiwa K., Asano M., Nagasaki Y., et al. TPH2 is not a susceptibility gene for suicide in Japanese population. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33(8):1546-1550.
30. Must A., Tasa G., Lang A., Vasar E., Koks S., Maron E., et al. Variation in tryptophan hydroxylase-2 gene is not associated to male completed suicide in Estonian population. Neuroscience Letters 2009, 453(2):112-114.
31. Nekanda-Trepka C.J., Bishop S., Blackburn I.M. Hopelessness and depression. British Journal of Clinical Psychology 1983, 22(Pt 1):49-60.
32. Perczel-Forintos D., Sallai J., R'zsa S. A Beck-féle Reménytelenség Skála Pszichometriai vizsgálata. Psychiatria Hungarica 2007, 6:632-643.
33. Perczel D.F., Rozsa S., Kopp M. An investigation of the short version of the Beck Hopelessness Scale in a national representative survey in Hungary. Psychiatria Hungarica 2007, 22(5):375-389.
34. Petty F., Kramer G., Wilson L. Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacology Biochemistry and Behavior 1992, 43(2):361-367.
35. Romera I., Delgado-Cohen H., Perez T., Caballero L., Gilaberte I. Factor analysis of the Zung self-rating depression scale in a large sample of patients with major depressive disorder in primary care. BMC Psychiatry 2008, 8:4.
36. Roy A., Nielsen D., Rylander G., Sarchiapone M., Segal N. Genetics of suicide in depression. The Journal of Clinical Psychiatry 1999, 60(Suppl 2):12-17. discussion 18-20, 113-6.
37. Roy A., Rylander G., Sarchiapone M. Genetic studies of suicidal behavior. The Psychiatric Clinics of North America 1997, 20(3):595-611.
38. Russ M.J., Lachman H.M., Kashdan T., Saito T., Bajmakovic-Kacila S. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide. Psychiatry Research 2000, 93(1):73-78.
39. Salter D., Platt S. Suicidal intent, hopelessness and depression in a parasuicide population: the influence of social desirability and elapsed time. British Journal of Clinical Psychology 1990, 29(Pt 4):361-371.
40. Samuelsson M., Jokinen J., Nordstrom A.L., Nordstrom P. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatrica Scandinavica 2006, 113(1):44-47.
41. Sidley G.L., Calam R., Wells A., Hughes T., Whitaker K. The prediction of parasuicide repetition in a high-risk group. British Journal of Clinical Psychology 1999, 38(Pt 4):375-386.
42. Szadoczky E., Papp Z., Vitrai J., Rihmer Z., Furedi J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. Journal of Affective Disorders 1998, 50(2-3):153-162.
43. Szanto K., Kalmar S., Hendin H., Rihmer Z., Mann J.J. A suicide prevention program in a region with a very high suicide rate. Archives of General Psychiatry 2007, 64(8):914-920.
44. Van Den Bogaert A., Sleegers K., De Zutter S., Heyrman L., Norrback K.F., Adolfsson R., et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Archives of General Psychiatry 2006, 63(10):1103-1110.
45. van Heeringen C., Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. Journal of Affective Disorders 2003, 74(2):149-158.
46. Wetzel R.D., Margulies T., Davis R., Karam E. Hopelessness, depression, and suicide intent. The Journal of Clinical Psychiatry 1980, 41(5):159-160.
47. Yoon H.K., Kim Y.K. TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(3):403-409.
48. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45(1):11-16.
49. Zhang Y., Zhang C., Yuan G., Yao J., Cheng Z., Liu C., et al. Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression. Behavioral and Brain Functions 2011, 6:49.
50. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., Taubman J., et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Archives of General Psychiatry 2005, 62(10):1109-1118.
51. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry 2004, 9(11):1030-1036.
52. Zill P., Buttner A., Eisenmenger W., Moller H.J., Ackenheil M., Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. Journal of Psychiatric Research 2007, 41(1-2):168-173.
53. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biological Psychiatry 2004, 56(8):581-586.